首页 > 抗体蛋白 > 抗体
Brilliant Violet 421™ anti-mouse CD19 Antibo
产品名称:
Brilliant Violet 421™ anti-mouse CD19 Antibo
产品类别:
抗体
产品编号:
115537
产品应用:
115537
[价格]
规格 价格 库存
125µL ¥ 1980 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CD19-expressing K562 human erythroleukemia cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
Concentration
?g sizes: 0.2 mg/mL
?L sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC-F - Verified

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the ?g size, the suggested use of this reagent is ≤ 0.25 ?g per million cells in 100 ?l volume. For immunofluorescent staining using ?l sizes, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.?For immunohistochemistry on Frozen tissue using the ?g size, a concentration range of 1.0 - 5.0 ?g/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunofluorescence7.

Application References

(PubMed link indicates BioLegend citation)
  1. Shoham T, et al. 2003. J. Immunol. 171:4062. (FC)
  2. Goodyear CS, et al. 2004. J. Immunol. 172:2870. (FC)
  3. Kamimura D, et al. 2006. J. Immunol. 177:306. (FC)
  4. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (FC)
  5. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  6. Phan TG, et al. 2007. Nat. Immunol. 8:992. (FC)
  7. Hayashida K, et al. 2008. J. Biol. Chem. 283:19895. (IF) PubMed
  8. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  9. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  10. Stadnisky MD, et al. 2011. Blood. 117:5133. (FC) PubMed
  11. Perlot T, et al. 2012. J. Immunol. 188:1201. (FC) PubMed
  12. Olive V, et al. 2013. Elife. 2:822. PubMed
  13. Miyai T, et al. 2014. PNAS. 111:11780. PubMed
Product Citations
  1. Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed
  2. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  3. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  4. Rosalia R, et al. 2013. Immunobiology. 218:851. PubMed
  5. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  6. Minutti CM, et al. 2019. Immunity. 50:645. PubMed
  7. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  8. Sangesland M, et al. 2020. Immunity. 51(4):735-749. PubMed
  9. Park JG, et al. 2021. iScience. 24(9):102941. PubMed
  10. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  11. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  12. Jackson-Jones LH, et al. 2020. Immunity. 52:700. PubMed
  13. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  14. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  15. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  16. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  17. Brown CC, et al. 2020. Cell. 179(4):846-863.e24.. PubMed
  18. Zheng Z, et al. 2020. Cell Reports. 31(13):107819. PubMed
  19. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  20. Prooyen N, et al. 2016. PLoS One. 12: 1005749. PubMed
  21. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  22. Dibra D, et al. 2016. Clin Cancer Res. 22: 3876 - 3883. PubMed
  23. Bello A, et al. 2021. Immunol Cell Biol. 99:879. PubMed
  24. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  25. Giampazolias E, et al. 2021. Cell. . PubMed
  26. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  27. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  28. Kerkhofs D, et al. 2020. Theranostics. 7.022222222. PubMed
  29. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  30. Akoolo L, et al. 2021. Cell Microbiol. 23:e13350. PubMed
  31. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  32. Heil J, et al. 2021. Nat Commun. 12:6963. PubMed
  33. Kelley WJ, et al. 2022. JCI Insight. :. PubMed
  34. Jolly A, et al. 2022. Cell Rep Methods. 2:100315. PubMed
  35. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  36. Monzon-Casanova E, et al. 2021. Eur J Immunol. 51:2266. PubMed
  37. Wang Y, et al. 2020. Immunity. 53(6):1151-1167.e6. PubMed
  38. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  39. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  40. Steinmetz TD, et al. 2021. Autophagy. 17:2238. PubMed
  41. Schaum N, et al. 2020. Nature. 583:596. PubMed
  42. Kleiman E, et al. 2016. Proc Natl Acad Sci U S A. 113: E3911 - E3920. PubMed
RRID
AB_10895761 (BioLegend Cat. No. 115537) AB_2563066 (BioLegend Cat. No. 115549) AB_11203527 (BioLegend Cat. No. 115538)

Antigen Details

Structure
Ig superfamily, associates with CD21 and CD81, 95 kD
Distribution

Pro-B cells to mature B cells (during development), follicular dendritic cells

Function
Modulates B cell activation and differentiation
Ligand/Receptor
CD21, CD81, Leu-13
Cell Type
B cells, Dendritic cells
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341.
2. Krop I, et al. 1996. Eur. J. Immunol. 26:238.
3. Krop I, et al. 1996. J. Immunol. 157:48.
4. Tedder TF, et al. 1994. Immunol. Today 15:437.

Gene ID
12478 View all products for this Gene ID
UniProt
View information about CD19 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线